<SEC-DOCUMENT>0001104659-26-004337-index.html : 20260116
<SEC-HEADER>0001104659-26-004337.hdr.sgml : 20260116
<ACCEPTANCE-DATETIME>20260116083651
ACCESSION NUMBER:		0001104659-26-004337
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		25
FILED AS OF DATE:		20260116
DATE AS OF CHANGE:		20260116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MetaVia Inc.
		CENTRAL INDEX KEY:			0001638287
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				472389984
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-292581
		FILM NUMBER:		26537724

	BUSINESS ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138
		BUSINESS PHONE:		(857) 702-9600

	MAIL ADDRESS:	
		STREET 1:		545 CONCORD AVENUE
		STREET 2:		SUITE 210
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02138

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeuroBo Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20191231

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gemphire Therapeutics Inc.
		DATE OF NAME CHANGE:	20150331
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>tm2528002-19_424b4.htm
<DESCRIPTION>424B4
<TEXT>
Document 1 - file: tm2528002-19_424b4.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_metavia-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_metavia-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fc_pipeline-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: fc_pipeline-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fc_mash-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: fc_mash-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>bc_exploratoryp1b-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: bc_exploratoryp1b-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bc_biomarker-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: bc_biomarker-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>bc_changesbaseline-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: bc_changesbaseline-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>bc_lsm1-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: bc_lsm1-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>bc_lsm2-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: bc_lsm2-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>bc_lsm3-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: bc_lsm3-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>bc_lsm4-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: bc_lsm4-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>bc_week16-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: bc_week16-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>bc_cfbpercentage-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 13 - file: bc_cfbpercentage-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ph_oxyntomodulin-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 14 - file: ph_oxyntomodulin-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>lc_preclinical-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 15 - file: lc_preclinical-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>bc_comparision-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 16 - file: bc_comparision-4clr.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tb_disposition-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 17 - file: tb_disposition-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tb_baseline-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 18 - file: tb_baseline-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tb_primarysafety-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 19 - file: tb_primarysafety-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>bc_exploratory-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 20 - file: bc_exploratory-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>bc_exploratoryweight-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 21 - file: bc_exploratoryweight-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tb_exploratorywaist-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 22 - file: tb_exploratorywaist-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tb_fastedglucose-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 23 - file: tb_fastedglucose-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tb_vctechange-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 24 - file: tb_vctechange-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tb_pkphase1-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 25 - file: tb_pkphase1-4c.jpg

</DOCUMENT>
</SEC-DOCUMENT>